ReviewExpert review of hematology2024

Evaluating zanubrutinib for the treatment of adults with chronic lymphocytic leukemia or small lymphocytic lymphoma.

Nathalie Javidi-Sharifi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.